Welcome to our dedicated page for Harte Hanks news (Ticker: HHS), a resource for investors and traders seeking the latest updates and insights on Harte Hanks stock.
Harte Hanks, Inc. (NASDAQ:HHS) is a global customer experience and data-driven marketing company whose news flow centers on financial performance, strategic partnerships, technology initiatives and transformation progress. The company regularly issues earnings releases detailing results for its Customer Care, Fulfillment & Logistics and Marketing Services segments, along with commentary on cost structure, EBITDA trends and balance sheet strength.
Investors following HHS news will see quarterly and full-year results, updates on its multi-year transformation program Project Elevate, and disclosures about leadership changes such as the appointment of a new President to oversee business segments and M&A initiatives. Harte Hanks also reports on material financing developments, including amendments to its asset-based revolving credit facility with Texas Capital Bank that extend maturities and add borrowing flexibility.
Operational and commercial updates are another key theme. Recent announcements include the opening of a dedicated Customer Care center in Greenville, South Carolina in partnership with Samsung Electronics America, and exclusive rights to license ADS Data Direct’s Medical Ailment Database to support compliant, high-precision healthcare marketing. The company also highlights collaborations with technology providers, such as its work with Reddy to apply AI-driven coaching and training within global contact center operations.
This news page aggregates these earnings releases, 8-K-linked announcements and corporate updates so readers can track how Harte Hanks executes its customer experience strategy, manages its capital resources and expands relationships with major brands across healthcare, technology, consumer, financial services and other sectors.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Harte Hanks, Inc. (NASDAQ:HHS) will announce its financial results for the first quarter ending March 31, 2023, on May 2, 2023, after market close. The company will host a conference call and live webcast at 4:30 p.m. EST on the same day to discuss these results.
Investors can access the webcast here or participate via phone at (888) 506-0062 in the U.S. and (973) 528-0011 internationally, using access code 483090. A replay will be available until May 16, 2023, through (877) 481-4010 from the U.S. and (919) 882-2331 internationally.
Harte Hanks is a customer experience company with a mission to deliver CX strategy and analytics, working with major brands like Pfizer and Ford.
Harte Hanks (NASDAQ:HHS) reported financial results for Q4 and the full year ended December 31, 2022, showcasing strong growth and a solid financial position. Q4 revenues rose 5.4% to $54.8 million, driven by a 34.4% increase in Fulfillment & Logistics Services. Annual revenues grew 6% to $206.3 million, with a significant boost in operating income to $15.1 million, up 97.8% year-over-year. Net income for the year was $36.8 million, aided by a $19.8 million tax benefit. The company eliminated debt and redeemed preferred shares, enhancing liquidity. For 2023, Harte Hanks anticipates continued revenue and EBITDA growth despite modest Q1 challenges.